The Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK) is seeking Pediatric Oncologists to join the Academic Pediatric Oncology Service who are devoted to the care of children with cancer from birth through young adulthood. Our mission includes research, education, clinical care, advocacy and community outreach. We are actively seeking physicians that are BE/BC in pediatrics and pediatric hematology/oncology interested in an academic career.
Faculty from the Academic Oncology Service serve as pediatric oncologists with special expertise in managing cancer patients both in the inpatient and ambulatory care settings. They care for a range of patients, from patients receiving stem cell transplants and novel cellular therapies to children with relapsed cancer enrolled on clinical trials, and establish continuity of care among our cancer specialists and referring physicians. The Academic Oncology faculty serve as the key educators of pediatric residents and fellows and conduct important clinical research and quality and safety initiatives within the Department of Pediatrics. Academic Oncology faculty will have protected time for these academic pursuits.
This search is open to potential candidates at all levels of career experience and appointments will be made at an academic level commensurate with the appointee’s experience. As a member of the Academic Oncology Service team you will have the responsibility for:
Direct patient care for pediatric general oncology. Clinical responsibilities include the following on a rotational basis: inpatient oncology service, stem cell transplant service, and primary care of outpatients in Memorial Sloan Kettering regional sites in NY and NJ.
Educational initiatives delivering curriculum on pediatric oncology for medical trainees (primarily residents) and licensed independent practitioners at all levels of practice in the department.
Protected time for academic pursuits based on candidate interests. Some examples include: Patient Safety / QI, Clinical Trials and research projects in collaboration with disease specific team.
Program development and quality improvement initiatives advancing integration and implementation of supportive care standards of care and evidence- based practices.
Memorial Sloan Kettering Cancer Center’s Department of Pediatrics is the nation’s largest pediatric cancer program dedicated to the treatment of children, teenagers, and young adults with cancer, immune deficiencies and blood disorders, with more than 800 new patients each year. Comprising leading experts in the treatment of pediatric malignancies and immune deficiencies, over 70 faculty members within the Department of Pediatrics are dedicated to seeking novel approaches to achieve more-effective outcomes while reducing or minimizing the short-and long-term effects of treatment, both in the laboratory and in state-of-the-art clinical facilities.
In addition to treatment, Memorial Sloan Kettering offers a wide range of support services to enhance quality of life and ease the experience of cancer on families. Care for children, adolescents, or young adults is provided in an adjoined inpatient and outpatient platform that incorporates family-friendly and age appropriate design. Contained within the pediatric care platform is also a Pediatric Intensive Care Unit for children who require a more-intensive inpatient support, and a Procedure Room for onsite anesthesia-staffed procedures.
Applicants must possess a full and unrestricted license to practice medicine in the State of New York (or must be licensed in another jurisdiction and be eligible for licensure in New York and New Jersey).
They must possess a Doctor of Medicine (MD), Osteopathy (DO) or equivalent.
Board-certified in Pediatrics; Board-certified or Board-eligible in Pediatric Hematology/Oncology.
Eligible for appointment at an academic rank ranging from Instructor to Assistant or Associate Professor.
Internal Number: M0035/100358
About Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center — the world’s oldest and largest comprehensive cancer center — has devoted more than 130 years to exceptional patient care, innovative research, and outstanding educational programs. Today, we are one of 50 National Cancer Institute–designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment.
The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available as we work to discover more-effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan Kettering has an impact on cancer treatment and biomedical research around the world.